Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Scherber RM"'
Publikováno v:
Health Education & Behavior; Oct2010, Vol. 37 Issue 5, p680-693, 14p
Autor:
Thomas JL, Stewart DW, Lynam IM, Daley CM, Befort C, Scherber RM, Mercurio AE, Okuyemi KS, Ahluwalia JS
Publikováno v:
American Journal of Health Behavior; Jul/Aug2009, Vol. 33 Issue 4, p339-352, 14p
Autor:
Găman MA; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania.; Department of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Romanian Academy, 030304 Bucharest, Romania., Scherber RM; Department of Hematology/Oncology, UT Health San Antonio, MD Anderson Cancer Center, San Antonio, TX 78229, USA., Ursuleac I; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania., Crişan AM; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania., Bădeliţă SN; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania., Ionescu BO; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania., Ghiaur AE; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania., Brînză M; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania., Pîrciulescu N; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania., Lascăr TO; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania., Diaconu CC; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Internal Medicine Clinic, Clinical Emergency Hospital of Bucharest, 105402 Bucharest, Romania., Găman AM; Department of Pathophysiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.; Clinic of Hematology, Filantropia City Hospital, 200143 Craiova, Romania., Coriu D; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2024 Jun 02; Vol. 13 (11). Date of Electronic Publication: 2024 Jun 02.
Autor:
Mendez Luque LF; University of California, Irvine School of Medicine, Irvine, California.; Teaching and Research Department, Institute of Public Health Services of the State of Baja California, Baja California, Mexico., Avelar-Barragan J; Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, California., Nguyen H; University of California, Irvine School of Medicine, Irvine, California., Nguyen J; University of California, Irvine School of Medicine, Irvine, California., Soyfer EM; University of California, Irvine School of Medicine, Irvine, California., Liu J; University of California, Irvine School of Medicine, Irvine, California., Chen JH; University of California, Irvine School of Medicine, Irvine, California., Mehrotra N; University of California, Irvine School of Medicine, Irvine, California., Huang X; University of California, Irvine School of Medicine, Irvine, California., Kosiorek HE; Department of Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, Arizona., Dueck A; Department of Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, Arizona., Himstead A; University of California, Irvine School of Medicine, Irvine, California., Heide E; University of California, Irvine School of Medicine, Irvine, California., Lem M; University of California, Irvine School of Medicine, Irvine, California., El Alaoui K; University of California, Irvine School of Medicine, Irvine, California., Mas E; University of California, Irvine School of Medicine, Irvine, California., Scherber RM; Mays Cancer Center, UT Health San Antonio, San Antonio, Texas., Mesa RA; Atrium Health, Levine Cancer Institute, Charlotte, North Carolina., Whiteson KL; Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, California., Odegaard A; University of California, Irvine School of Medicine, Irvine, California., Fleischman AG; University of California, Irvine School of Medicine, Irvine, California.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Mar 05; Vol. 4 (3), pp. 660-670.
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase.
Autor:
Mendez Luque LF; University of California, Irvine School of Medicine.; Teaching and Research Department, Institute of Public Health Services of the State of Baja California., Avelar-Barragan J; Department of Molecular Biology and Biochemistry, University of California Irvine., Nguyen H; University of California, Irvine School of Medicine., Nguyen J; University of California, Irvine School of Medicine., Soyfer EM; University of California, Irvine School of Medicine., Liu J; University of California, Irvine School of Medicine., Chen JH; University of California, Irvine School of Medicine., Mehrotra N; University of California, Irvine School of Medicine., Kosiorek HE; Department of Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, AZ., Dueck A; Department of Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, AZ., Himstead A; University of California, Irvine School of Medicine., Heide E; University of California, Irvine School of Medicine., Lem M; University of California, Irvine School of Medicine., Alaoui KE; University of California, Irvine School of Medicine., Marin EM; University of California, Irvine School of Medicine., Scherber RM; Mays Cancer Center, UT Health San Antonio., Mesa RA; Atrium Health, Levine Cancer Institute, Charlotte, NC., Whiteson KL; Department of Molecular Biology and Biochemistry, University of California Irvine., Odegaard A; University of California, Irvine School of Medicine., Fleischman AG; University of California, Irvine School of Medicine.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2023 May 12. Date of Electronic Publication: 2023 May 12.
Autor:
Kosiorek HE; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA., Scherber RM; Blueprint Medicines, Cambridge, Massachusetts, USA., Geyer HL; Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA., Verstovsek S; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA., Langlais BT; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA., Mazza GL; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA., Gotlib J; Stanford University Medical Center, Palo Alto, California, USA., Gupta V; MPN Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Padrnos LJ; Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA., Palmer JM; Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA., Fleischman A; Department of Hematology and Oncology, University of California Irvine, Irvine, California, USA., Mesa RA; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, Texas, USA., Dueck AC; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Sep; Vol. 198 (6), pp. 1065-1068. Date of Electronic Publication: 2022 Jun 24.
Autor:
Pemmaraju N; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Electronic address: npemmaraju@mdanderson.org., Gerds AT; Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave, Cleveland, OH 44195, USA. Electronic address: gerdsa@ccf.org., Yu J; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, DE 19803, USA. Electronic address: jyu@incyte.com., Parasuraman S; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, DE 19803, USA. Electronic address: sparasuraman@incyte.com., Shah A; Avalere Health, 1201 New York Ave NW, Washington, DC 20005, USA. Electronic address: anneshah04@gmail.com., Xi A; Avalere Health, 1201 New York Ave NW, Washington, DC 20005, USA. Electronic address: annxi14@gmail.com., Kumar S; Avalere Health, 1201 New York Ave NW, Washington, DC 20005, USA. Electronic address: skumar@avalere.com., Scherber RM; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, DE 19803, USA; Mays Cancer Institute at UT Health San Antonio MD Anderson, San Antonio, TX, USA. Electronic address: rscherber@incyte.com., Verstovsek S; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Electronic address: sverstov@mdanderson.org.
Publikováno v:
Leukemia research [Leuk Res] 2022 Apr; Vol. 115, pp. 106809. Date of Electronic Publication: 2022 Feb 16.
Autor:
Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yu J; Incyte Corporation, Wilmington, DE, USA., Scherber RM; Incyte Corporation, Wilmington, DE, USA., Verma S; STATinMED Research, Plano, TX, USA., Dieyi C; STATinMED Research, Plano, TX, USA., Chen CC; STATinMED Research, Plano, TX, USA., Parasuraman S; Incyte Corporation, Wilmington, DE, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Mar; Vol. 63 (3), pp. 694-702. Date of Electronic Publication: 2021 Oct 25.
Autor:
Gerds AT; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Yu J; Incyte Corporation, Wilmington, Delaware, USA, jyu@incyte.com., Scherber RM; Incyte Corporation, Wilmington, Delaware, USA., Paranagama D; Incyte Corporation, Wilmington, Delaware, USA., Kish JK; Cardinal Health Specialty Solutions, Dublin, Ohio, USA., Visaria J; HealthCore, Inc., Wilmington, Delaware, USA., Singhal M; HealthCore, Inc., Wilmington, Delaware, USA., Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pemmaraju N; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Acta haematologica [Acta Haematol] 2022; Vol. 145 (4), pp. 448-453. Date of Electronic Publication: 2022 Jan 10.
Autor:
Verstovsek S; The University of Texas MD Anderson Cancer Center, Leukemia Department, 1515 Holcombe Blvd, Houston, TX 77030, USA. Electronic address: sverstov@mdanderson.org., Amoloja T; Incyte Corporation, 1801 Augustine Cut-off, Wilmington, DE 19803, USA. Electronic address: tamoloja@incyte.com., Scherber RM; Incyte Corporation, 1801 Augustine Cut-off, Wilmington, DE 19803, USA. Electronic address: rscherber@incyte.com., Yu J; Incyte Corporation, 1801 Augustine Cut-off, Wilmington, DE 19803, USA. Electronic address: jyu@incyte.com.
Publikováno v:
Leukemia research [Leuk Res] 2021 Nov; Vol. 110, pp. 106711. Date of Electronic Publication: 2021 Sep 22.